Publication Cover
Journal of Environmental Science and Health, Part C
Environmental Carcinogenesis and Ecotoxicology Reviews
Volume 28, 2010 - Issue 1
283
Views
19
CrossRef citations to date
0
Altmetric
Original Articles

Gene Expression Profiling as an Initial Approach for Mechanistic Studies of Toxicity and Tumorigenicity of Herbal Plants and Herbal Dietary Supplements

, , , , &
Pages 60-87 | Published online: 18 Mar 2010

REFERENCES

  • Zurer , P and Hanson , D . 2004 . Chemistry puts herbal supplements to the test . Chemical & Engineering News , 82 : 16
  • Ho , C H , Simon , J C , Shahidi , F and Shao , Y . 2008 . Dietary supplements: an overview , Dietary Supplements (ACS Symposium Series 987) 2 – 8 . Washington, DC : American Chemical Society .
  • Arneborn , P , Jansson , A and Bottiger , Y . 2005 . [Acute hepatitis in a woman after intake of slimming pills bought via Internet] . Lakartidningen , 102 : 2071 – 2 .
  • Bujanda , L , Palacios , A , Silvarino , R , Sanchez , A and Munoz , C . 2002 . [Kava-induced acute icteric hepatitis] . Gastroenterol. Hepatol , 25 : 434 – 5 .
  • CDC . 2002 . Hepatic toxicity possibly associated with kava-containing products—United States, Germany, and Switzerland, 1999–2002 . Morbidity and Mortality Weekly Reports (MMWR) , : 1065 – 67 .
  • Durazo , F A , Lassman , C , Han , S H , Saab , S , Lee , N P , Kawano , M , Saggi , B , Gordon , S , Farmer , D G , Yersiz , H , Goldstein , R L , Ghobrial , M and Busuttil , R W . 2004 . Fulminant liver failure due to usnic acid for weight loss . Am. J. Gastroenterol , 99 : 950 – 2 .
  • Chan , P C , Xia , Q and Fu , P P . 2007 . Ginkgo biloba leave extract: biological, medicinal, and toxicological effects . J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev , 25 : 211 – 44 .
  • Fu , P P , Xia , Q , Guo , L , Yu , H and Chan , P C . 2008 . Toxicity of kava kava . J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev , 26 : 89 – 112 .
  • Guo , L , Shi , Q , Fang , J L , Mei , N , Ali , A A , Lewis , S M , Leakey , J E and Frankos , V H . 2008 . Review of usnic acid and Usnea barbata toxicity . J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev , 26 : 317 – 38 .
  • Gurley , B J , Swain , A , Barone , G W , Williams , D K , Breen , P , Yates , C R , Stuart , L B , Hubbard , M A , Tong , Y and Cheboyina , S . 2007 . Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans . Drug Metab. Dispos , 35 : 240 – 5 .
  • Hu , Z , Yang , X , Ho , P C , Chan , S Y , Heng , P W , Chan , E , Duan , W , Koh , H L and Zhou , S . 2005 . Herb-drug interactions: a literature review . Drugs , 65 : 1239 – 82 .
  • Mei , N , Guo , L , Liu , R , Fuscoe , J C and Chen , T . 2007 . Gene expression changes induced by the tumorigenic pyrrolizidine alkaloid riddelliine in liver of Big Blue rats . BMC Bioinformatics , 8 ( Suppl 7 ) : S4
  • Singh , Y N . 2005 . Potential for interaction of kava and St. John's wort with drugs . J. Ethnopharmacol , 100 : 108 – 13 .
  • CFSAN . 2001 . FDA warns consumers not to use the dietary supplement LipoKinetix Available at http://wwwcfsanfdagov/~dms/ds-lipohtml
  • CFSAN . 2001 . Letter to distributor on hazardous dietary supplement LipoKinetix Available at http://wwwcfsanfdagov/~dms/ds-ltr26html
  • CFSAN . March 25 2002 . Center for Food Safety and Applied Nutrition (CFSAN): Kava-containing dietary supplements may be associated with severe liver injury , March 25 , Rockville, Maryland : U.S. Department of Health and Human Services, Food and Drug Administration . Available at http://www.cfsan.fda.gov/~dms/ds-warn.html
  • FDA . 2004 . FDA Public Health News, FDA announced major initiatives for dietary supplements
  • Available at http://ntp.niehs.nih.gov/?objectid=72016262-BDB7-CEBA-FA60E922B18C2540 Report on carcinogen
  • Borgert , C J . 2007 . Predicting interactions from mechanistic information: can omic data validate theories? . Toxicol. Appl. Pharmacol , 223 : 114 – 20 .
  • Borgert , C J , Quill , T F , McCarty , L S and Mason , A M . 2004 . Can mode of action predict mixture toxicity for risk assessment? . Toxicol. Appl. Pharmacol , 201 : 85 – 96 .
  • Hamadeh , H K , Bushel , P R , Jayadev , S , Martin , K , DiSorbo , O , Sieber , S , Bennett , L , Tennant , R , Stoll , R , Barrett , J C , Blanchard , K , Paules , R S and Afshari , C A . 2002 . Gene expression analysis reveals chemical-specific profiles . Toxicol. Sci , 67 : 219 – 31 .
  • Waring , J F , Ciurlionis , R , Jolly , R A , Heindel , M and Ulrich , R G . 2001 . Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity . Toxicol. Lett , 120 : 359 – 68 .
  • Waters , M D and Fostel , J M . 2004 . Toxicogenomics and systems toxicology: aims and prospects . Nat. Rev. Genet , 5 : 936 – 48 .
  • NAP . 2005 . Communicating toxicogenomics information to nonexperts: a workshop summary , The National Academies Press .
  • Boverhof , D R and Zacharewski , T R . 2006 . Toxicogenomics in risk assessment: applications and needs . Toxicol. Sci , 89 : 352 – 60 .
  • Dix , D J , Houck , K A , Martin , M T , Richard , A M , Setzer , R W and Kavlock , R J . 2007 . The ToxCast program for prioritizing toxicity testing of environmental chemicals . Toxicol. Sci , 95 : 5 – 12 .
  • Waring , J F , Jolly , R A , Ciurlionis , R , Lum , P Y , Praestgaard , J T , Morfitt , D C , Buratto , B , Roberts , C , Schadt , E and Ulrich , R G . 2001 . Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles . Toxicol. Appl. Pharmacol , 175 : 28 – 42 .
  • Afshari , C A , Nuwaysir , E F and Barrett , J C . 1999 . Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation . Cancer Res , 59 : 4759 – 60 .
  • Chen , T , Guo , L , Zhang , L , Shi , L , Fang , H , Sun , Y , Fuscoe , J C and Mei , N . 2006 . Gene expression profiles distinguish the carcinogenic effects of aristolochic acid in target (kidney) and non-target (liver) tissues in rats . BMC Bioinformatics , 7 ( Suppl 2 ) : S20
  • Chou , M W and Fu , P P . 2006 . Formation of DHP-derived DNA adducts in vivo from dietary supplements and chinese herbal plant extracts containing carcinogenic pyrrolizidine alkaloids . Toxicol. Ind. Health , 22 : 321 – 7 .
  • Guo , L , Li , Q , Xia , Q , Dial , S , Chan , P C and Fu , P . 2009 . Analysis of gene expression changes of drug metabolizing enzymes in the livers of F344 rats following oral treatment with kava extract . Food Chem. Toxicol , 47 : 433 – 42 .
  • Guo , L , Mei , N , Liao , W , Chan , P C and Fu , P . 2010 . Ginkgo biloba extract induces gene expression changes in xenobiotics metabolism and the myc-centered network . OMICS , 14 : 75 – 90 .
  • Guo , L , Shi , Q. , Dial , S , Xia , Q , Mei , N , Li , Q , Chan , P C and Fu , P . 2010 . Gene expression profiling in male B6C3F1 mouse livers exposed to kava identifies changes in drug metabolizing genes and potential mechanisms linked to kava toxicity . Food Chem. Toxicol , 48 : 686 – 696 .
  • Mei , N , Guo , L , Fu , P P , Heflich , R H and Chen , T . 2005 . Mutagenicity of comfrey (Symphytum Officinale) in rat liver . Br. J. Cancer , 92 : 873 – 5 .
  • Mei , N , Guo , L , Tseng , J , Dial , S L , Liao , W and Manjanatha , M G . 2008 . Gene expression changes associated with xenobiotic metabolism pathways in mice exposed to acrylamide . Environ. Mol. Mutagen , 49 : 741 – 5 .
  • Mei , N , Guo , L , Zhang , L , Shi , L , Sun , Y A , Fung , C , Moland , C L , Dial , S L , Fuscoe , J C and Chen , T . 2006 . Analysis of gene expression changes in relation to toxicity and tumorigenesis in the livers of Big Blue transgenic rats fed comfrey (Symphytum officinale) . BMC Bioinformatics , 7 ( Suppl 2 ) : S16
  • Driver , S , Baxter , K and Williamson , E . 2009 . Stockley's herbal medicines interactios . Pharmaceutical Press , : 1 – 11 .
  • Kaplowitz , N . 1997 . Hepatotoxicity of herbal remedies: insights into the intricacies of plant-animal warfare and cell death . Gastroenterology , 113 : 1408 – 12 .
  • Zhou , S , Gao , Y , Jiang , W , Huang , M , Xu , A and Paxton , J W . 2003 . Interactions of herbs with cytochrome P450 . Drug. Metab. Rev , 35 : 35 – 98 .
  • Bjornsson , T D , Callaghan , J T , Einolf , H J , Fischer , V , Gan , L , Grimm , S , Kao , J , King , S P , Miwa , G , Ni , L , Kumar , G , McLeod , J , Obach , R S , Roberts , S , Roe , A , Shah , A , Snikeris , F , Sullivan , J T , Tweedie , D , Vega , J M , Walsh , J and Wrighton , S A . 2003 . The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective . Drug Metab. Dispos , 31 : 815 – 32 .
  • Huang , S M , Strong , J M , Zhang , L , Reynolds , K S , Nallani , S , Temple , R , Abraham , S , Habet , S A , Baweja , R K , Burckart , G J , Chung , S , Colangelo , P , Frucht , D , Green , M D , Hepp , P , Karnaukhova , E , Ko , H S , Lee , J I , Marroum , P J , Norden , J M , Qiu , W , Rahman , A , Sobel , S , Stifano , T , Thummel , K , Wei , X X , Yasuda , S , Zheng , J H , Zhao , H and Lesko , L J . 2008 . New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process . J. Clin. Pharmacol , 48 : 662 – 70 .
  • Fuhr , U . 2000 . Induction of drug metabolising enzymes: pharmacokinetic and toxicological consequences in humans . Clin. Pharmacokinet , 38 : 493 – 504 .
  • Iyer , K R and Sinz , M W . 1999 . Characterization of Phase I Phase II hepatic drug metabolism activities in a panel of human liver preparations . Chem. Biol. Interact , 118 : 151 – 69 .
  • Roymans , D , Van Looveren , C , Leone , A , Parker , J B , McMillian , M , Johnson , M D , Koganti , A , Gilissen , R , Silber , P , Mannens , G and Meuldermans , W . 2004 . Determination of cytochrome P450 1A2 and cytochrome P450 3A4 induction in cryopreserved human hepatocytes . Biochem. Pharmacol , 67 : 427 – 37 .
  • Dentali , S J . 1997 . Herb safety review: kava, piper methysticum forster f. (Piperaceae) , Bethesda, MD : American Herbal Products Association .
  • Campo , J V , McNabb , J , Perel , J M , Mazariegos , G V , Hasegawa , S L and Reyes , J . 2002 . Kava-induced fulminant hepatic failure . J. Am. Acad. Child Adolesc. Psychiatry , 41 : 631 – 2 .
  • Clough , A R , Bailie , R S and Currie , B . 2003 . Liver function test abnormalities in users of aqueous kava extracts . J. Toxicol. Clin. Toxicol , 41 : 821 – 9 .
  • Humberston , C L , Akhtar , J and Krenzelok , E P . 2003 . Acute hepatitis induced by kava kava . J. Toxicol. Clin. Toxicol , 41 : 109 – 13 .
  • Parkman , C A . 2002 . Another FDA warning: kava supplements . Case Manager , 13 : 26 – 8 .
  • Russmann , S , Barguil , Y , Cabalion , P , Kritsanida , M , Duhet , D and Lauterburg , B H . 2003 . Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia . Eur. J. Gastroenterol. Hepatol , 15 : 1033 – 6 .
  • Russmann , S , Lauterburg , B H and Helbling , A . 2001 . Kava hepatotoxicity . Ann. Intern. Med , 135 : 68 – 9 .
  • Clayton , N P , Yoshizawa , K , Kissling , G E , Burka , L T , Chan , P C and Nyska , A . 2007 . Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract . Exp. Toxicol. Pathol , 58 : 223 – 36 .
  • Parte , P and Kupfer , D . 2005 . Oxidation of tamoxifen by human flavin-containing monooxygenase (FMO) 1 and FMO3 to tamoxifen-N-oxide and its novel reduction back to tamoxifen by human cytochromes P450 and hemoglobin . Drug Metab. Dispos , 33 : 1446 – 52 .
  • Klick , D E and Hines , R N . 2007 . Mechanisms regulating human FMO3 transcription . Drug Metab. Rev , 39 : 419 – 42 .
  • Ciraulo , D A , Shader , R I , Greenblatt , D J and Creelman , W . 2005 . Drug interaction in psychiatry , Baltimore : Lippincott Williams & Wilkins .
  • Clouatre , D L . 2004 . Kava kava: examining new reports of toxicity . Toxicol. Lett , 150 : 85 – 96 .
  • Gonzalez , F J and Gelboin , H V . 1994 . Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins . Drug Metab. Rev , 26 : 165 – 83 .
  • Gonzalez , F J and Yu , A M . 2006 . Cytochrome P450 and xenobiotic receptor humanized mice . Annu. Rev. Pharmacol. Toxicol , 46 : 41 – 64 .
  • Bressler , R . 2005 . Herb-drug interactions: interactions between kava and prescription medications . Geriatrics , 60 : 24 – 5 .
  • Gurley , B J , Gardner , S F , Hubbard , M A , Williams , D K , Gentry , W B , Cui , Y and Ang , C Y . 2005 . Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba . Drugs Aging , 22 : 525 – 39 .
  • Mathews , J M , Etheridge , A S and Black , S R . 2002 . Inhibition of human cytochrome P450 activities by kava extract and kavalactones . Drug Metab. Dispos , 30 : 1153 – 7 .
  • Singh , Y N . 1992 . Kava: an overview . J. Ethnopharmacol , 37 : 13 – 45 .
  • Lim , S T , Dragull , K , Tang , C S , Bittenbender , H C , Efird , J T and Nerurkar , P V . 2007 . Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats . Toxicol. Sci , 97 : 214 – 21 .
  • Kensler , T W , Wakabayashi , N and Biswal , S . 2007 . Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway . Annu. Rev. Pharmacol. Toxicol , 47 : 89 – 116 .
  • Chan , K , Han , X D and Kan , Y W . 2001 . An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen . Proc. Natl. Acad. Sci. USA , 98 : 4611 – 6 .
  • Ramos-Gomez , M , Kwak , M K , Dolan , P M , Itoh , K , Yamamoto , M , Talalay , P and Kensler , T W . 2001 . Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice . Proc. Natl. Acad. Sci. USA , 98 : 3410 – 5 .
  • Aleksunes , L M and Manautou , J E . 2007 . Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease . Toxicol. Pathol , 35 : 459 – 73 .
  • Shen , G , Hebbar , V , Nair , S , Xu , C , Li , W , Lin , W , Keum , Y S , Han , J , Gallo , M A and Kong , A N . 2004 . Regulation of Nrf2 transactivation domain activity. The differential effects of mitogen-activated protein kinase cascades and synergistic stimulatory effect of Raf and CREB-binding protein . J. Biol. Chem , 279 : 23052 – 60 .
  • Wruck , C J , Gotz , M E , Herdegen , T , Varoga , D , Brandenburg , L O and Pufe , T . 2008 . Kavalactones protect neural cells against amyloid beta peptide-induced neurotoxicity via extracellular signal-regulated kinase 1/2-dependent nuclear factor erythroid 2-related factor 2 activation . Mol. Pharmacol , 73 : 1785 – 95 .
  • Joseph , A , Lee , T , Moland , C L , Branham , W S , Fuscoe , J C , Leakey , J E , Allaben , W T , Lewis , S M , Ali , A A and Desai , V G . 2009 . Effect of (+)-usnic acid on mitochondrial functions as measured by mitochondria-specific oligonucleotide microarray in liver of B6C3F1 mice . Mitochondrion , 9 : 149 – 58 .
  • Desai , V G , Lee , T , Delongchamp , R R , Moland , C L , Branham , W S , Fuscoe , J C and Leakey , J E . 2007 . Development of mitochondria-specific mouse oligonucleotide microarray and validation of data by real-time PCR . Mitochondrion , 7 : 322 – 9 .
  • Fu , P P , Xia , Q , Lin , G and Chou , M W . 2004 . Pyrrolizidine alkaloids—genotoxicity, metabolism enzymes, metabolic activation, and mechanisms . Drug Metab. Rev , 36 : 1 – 55 .
  • Martignoni , M , Groothuis , G M and de Kanter , R . 2006 . Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction . Expert Opin. Drug Metab. Toxicol , 2 : 875 – 94 .
  • Guo , L , Mei , N , Dial , S , Fuscoe , J and Chen , T . 2007 . Comparison of gene expression profiles altered by comfrey and riddelliine in rat liver . BMC Bioinformatics , 8 ( Suppl 7 ) : S22

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.